• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Eli Lilly (NY:LLY)

    920.87 +2.82 (+0.31%)
    Streaming Delayed Price Updated: 12:20 PM EDT, Mar 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Eli Lilly

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    Is It Too Late to Buy Eli Lilly? ↗
    Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Should You Buy the Vanguard S&P 500 ETF After the Recent Stock Market Sell-Off? History Offers a Crystal-Clear Answer. ↗
    Volatility in the stock market often leads to great long-term opportunities for investors. 
    Via The Motley Fool
    Topics ETFs Economy Stocks
    News headline image
    1 Reason I'm Never Selling Novo Nordisk Stock ↗
    I am not turned off by the company's recent setbacks. 
    Via The Motley Fool
    News headline image
    Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial ↗
    Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks. 
    Via Investor's Business Daily
    News headline image
    AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
    The pharmaceutical giant AbbVie (NYSE: ABBV) experienced a sharp decline on Wednesday, March 18, 2026, as its stock price tumbled to its lowest level since mid-2025. Shares of the Illinois-based... 
    Via MarketMinute
    Topics ETFs Economy Intellectual Property
    News headline image
    Stock Of The Day: Is The Eli Lilly Selloff Over? ↗
    Eli Lilly shares made a large move lower. But they are oversold and getting close to a level where there may be support. 
    Via Benzinga
    News headline image
    Ardsley Dumps 440,000 Hut 8 Shares Worth $19.4 Million ↗
    Hut 8 operates large-scale data centers supporting Bitcoin mining and high-performance computing for institutional clients. 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
    In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from... 
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot
    As of March 18, 2026, Hims & Hers Health (NYSE: HIMS) has reclaimed its position as the primary protagonist in the direct-to-consumer (DTC) healthcare narrative. Following a turbulent start to the year... 
    Via Finterra
    Topics Intellectual Property
    News headline image
    Members of Congress Bought These 5 Stocks—Should You? ↗
    Via MarketBeat
    Airlines Take Flight While Oil Burns: Markets Edge Higher Amid Middle East Tensions ↗
    Via Chartmill
    News headline image
    Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
    Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗
    Each of these companies could benefit from this high-growth market over time. 
    Via The Motley Fool
    News headline image
    Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move ↗
    These companies are benefiting from a tidal wave of demand for new weight-loss drugs. 
    Via The Motley Fool
    Topics Stocks
    News headline image
    Stock Market Today, March 17: Markets Edge Upwards as Fed Meeting Opens ↗
    Today, March 17, 2026, selective tech gains helped lift the Nasdaq even as oil prices and geopolitical tensions stayed elevated. 
    Via The Motley Fool
    Topics Economy Stocks
    News headline image
    Why Eli Lilly (LLY) Shares Are Plunging Today
    What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 6.3% in the afternoon session after investment bank HSBC downgraded the stoc... 
    Via StockStory
    News headline image
    Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure ↗
    You don't have to go all in to profit from AI. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Which S&P500 stocks are moving on Tuesday? ↗
    Via Chartmill
    News headline image
    LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff ↗
    The analyst’s new price target represents a potential downside of about 14% from the stock’s last closing price on Monday. 
    Via Stocktwits
    Tuesday's session: top gainers and losers in the S&P500 index ↗
    Via Chartmill
    News headline image
    Why Eli Lilly Stock Just Dropped ↗
    Eli Lilly's stock price is based on growth rates that might fall short. 
    Via The Motley Fool
    News headline image
    Eli Lilly Analyst Flags Overhyped Obesity Drug Expectations ↗
    HSBC downgrades Eli Lilly to reduce, citing pricing pressure, rising competition, and overestimated obesity drug market growth expectations. 
    Via Benzinga
    Tuesday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill
    News headline image
    This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock ↗
    Novo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development. 
    Via The Motley Fool
    News headline image
    Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
    Pfizer has reached a turning point. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Is There Too Much Bullishness Priced Into Eli Lilly's Stock Price? ↗
    Eli Lilly's stock is down this year, and its high valuation may be a big reason why. 
    Via The Motley Fool
    News headline image
    Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
    Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks ↗
    The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending. 
    Via The Motley Fool
    News headline image
    Eli Lilly's Eczema Drug Shows Strong Skin Clearance In Phase 3 Pediatric Trial ↗
    Eli Lilly's Phase 3 results for Ebglyss in children with severe eczema, shows skin clearance and itch relief in trial patients. 
    Via Benzinga
    News headline image
    3 Companies at the Forefront of the GLP-1 Pill Wars ↗
    Via MarketBeat
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.